Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Dorobac Doripenem For Injection, 500 mg
Dorobac, provided by Lexaro Healthcare, contains 500 mg of Doripenem per vial. Doripenem is a member of the carbapenem class of antibiotics, known for its broad-spectrum activity against a wide range of gram-positive and gram-negative bacteria. This formulation is specifically designed for intravenous administration to treat serious infections where oral antibiotics may be inadequate.
Uses of Dorobac Doripenem For Injection, 500 mg
Dorobac is primarily used for:
Treating severe infections including intra-abdominal infections, urinary tract infections, and skin and soft tissue infections.
Managing infections caused by multi-drug resistant organisms.
Providing effective treatment for complicated pneumonia and bacterial infections in hospitalized patients.
Addressing infections where other antibiotics may not be effective.
Benefits of Dorobac Doripenem For Injection, 500 mg
Offers broad-spectrum antibacterial activity, covering a wide range of pathogens.
Effective in treating severe and complicated infections where other antibiotics may fail.
Suitable for use in critically ill patients and those with resistant infections.
Administered intravenously for rapid onset of action and high bioavailability.
Well-tolerated with a favorable safety profile when used as directed.
Mechanism of Action of Dorobac Doripenem For Injection, 500 mg
Doripenem works by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs). This inhibition disrupts the cross-linking of peptidoglycan layers in the bacterial cell wall, leading to cell lysis and death. As a carbapenem antibiotic, Doripenem exhibits a broad spectrum of activity, including resistance to many beta-lactamases that typically inactivate other antibiotics. This makes Dorobac an effective choice for treating severe and multi-drug resistant bacterial infections.